Ardelyx | ARDX - Gross Profit On Sales

Stock Price
7.34
Daily Change
0.34 4.86%
Monthly
25.90%
Yearly
31.54%
Q1 Forecast
7.45

Ardelyx reported $106.35M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Amgen USD 6.48B 307M Sep/2025
Ardelyx USD 106.35M 23.51M Sep/2025
aTyr Pharma USD 190K 15.57M Sep/2025
Corcept Therapeutics USD 203.04M 12.04M Sep/2025
Sanofi EUR 8.45B 3.02B Dec/2025
TG Therapeutics USD 133.62M 11.41M Sep/2025
United Therapeutics USD 602.1M 108.9M Sep/2025